SSRI Antidepressant Medications: Adverse Effects and Tolerability
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been routinely identified to cause less severe withdrawal effects than other SSRIs, which has been attributed to its longer half-life 3,30,75 .”
From Tapering of SSRI treatment to mitigate withdrawal symptoms (2019) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However many of these drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
From Molecular and anatomical organization of the dorsal raphe nucleus (2019) · cites this paper as Ferguson, 2001
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“During long-term use of SSRIs, the most troubling adverse effects seem to be gastrointestinal problems, sleep disturbances and sexual dysfunction,49”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“often intolerable side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many patients refusing to take traditional antidepressants due to their side-effects”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [260]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
The Arizona Sexual Experience Scale (ASEX): Reliability and Validity
A. McGahuey, A. J. G. (2000) · Journal of Sex & Marital Therapy · doi:10.1080/009262300278623 · Cited by 1,155
Effects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
1995 Physicians' Desk Reference
Schild, S. M. (1995) · AORN Journal · doi:10.1016/s0001-2092(06)63819-2 · Cited by 497
Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors
Edwards, J. G., & Anderson, I. (1999) · Drugs · doi:10.2165/00003495-199957040-00005 · Cited by 458
Mechanism of action of antidepressant medications.
Feighner, J. P. (1999) · PubMed · Cited by 323
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<11::aid-da4>3.0.co;2-i · Cited by 266
Spigset, O. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00007 · Cited by 225
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder: A Controlled Trial
Monteiro, W. O., Noshirvani, H. F., Marks, I. M., & Lelliott, P. T. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 201
Cited by
Exercise as a treatment for depression: A meta-analysis
Kvam, S., Kleppe, C. L., Nordhus, I. H., & Hovland, A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.063 · Cited by 837
“Combining different pharmacological drugs increase the risk of adverse effects or drug-drug interaction (Ferguson, 2001; Gillman, 2007), which necessitates further exploration of adjunction with nonpharmacological treatments.”
BackgroundKravitz, R. L., Epstein, R. M., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., & Franks, P. (2005) · JAMA · doi:10.1001/jama.293.16.1995 · Cited by 586
Exploring the association between childhood and adolescent obesity and depression: A meta-analysis
Quek, Y., Tam, W. W. S., Zhang, M. W. B., & Ho, R. C. M. (2017) · Obesity Reviews · doi:10.1111/obr.12535 · Cited by 503
“Several studies have even linked long-term weight gain (73,74) with specific serotonin reuptake inhibitors, the most commonly prescribed class of antidepressants for childhood and adolescent depression, and which are usually acutely associated with weight loss.”
BackgroundDavies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
“In addition to the obvious economic costs incurred, the human costs of long-term use are well documented, being linked with serious adverse effects such as increased severe side-effects, (Ferguson, 2001) the impairment of patients' autonomy and resilience (increasing their dependence on medical help) (Kendrick, 2015),…”
BackgroundA meta-analysis of the use of probiotics to alleviate depressive symptoms
Ng, Q. X., Peters, C., Ho, C. Y. X., Lim, D. Y., & Yeo, W.-S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.063 · Cited by 357
Gut microbiota Turicibacter strains differentially modify bile acids and host lipids
Lynch, J. B., Gonzalez, E. L., Choy, K., Faull, K. F., Jewell, T., Arellano, A., Liang, J., Yu, K. B., Paramo, J., & Hsiao, E. Y. (2023) · Nature Communications · doi:10.1038/s41467-023-39403-7 · Cited by 347
Hudak, R., & Gannon, J. M. (2022) · Current Clinical Practice · doi:10.1007/978-3-030-98709-1_5 · Cited by 306
Disentangling neural cell diversity using single-cell transcriptomics
Poulin, J.-F., Tasic, B., Hjerling-Leffler, J., Trimarchi, J. M., & Awatramani, R. (2016) · Nature Neuroscience · doi:10.1038/nn.4366 · Cited by 293
Chase, H. W., Boudewyn, M. A., Carter, C. S., & Phillips, M. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0499-9 · Cited by 286
“Thus tDCS compares favorably with other therapeutic approaches such as antidepressants [6] or transcranial magnetic simu-”
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Kopschina Feltes, P., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A., Moriguchi-Jeckel, C. M., & de Vries, E. F. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711708 · Cited by 279
“Moreover, TCAs have a narrow therapeutic index and at higher doses, they might cause seizures and death due to slowing of intraventricular conduction, leading to complete heart block or ventricular re-entry arrhythmias (Ferguson, 2001).”
BackgroundLew, L.-C., Hor, Y.-Y., Yusoff, N. A. A., Choi, S.-B., Yusoff, M. S. B., Roslan, N. S., Ahmad, A., Mohammad, J. A. M., Abdullah, M. F. I. L., Zakaria, N., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.09.010 · Cited by 272
Van der Heijden, K. B., Smits, M. G., Someren, E. J. W. V., & Boudewijn Gunning, W. (2005) · Chronobiology International · doi:10.1081/cbi-200062410 · Cited by 269
“, 1993), selective serotonin reuptake inhibitors (SSRIs) (Ferguson, 2001), and benzodiazepines (Holbrook et al.”
BackgroundMolecular and anatomical organization of the dorsal raphe nucleus
Huang, K. W., Ochandarena, N. E., Philson, A. C., Hyun, M., Birnbaum, J. E., Cicconet, M., & Sabatini, B. L. (2019) · eLife · doi:10.7554/elife.46464 · Cited by 267
“However many of these 29 drugs can acutely induce adverse side effects including anxiety and increased risk of suicidal 30 behaviors (Ferguson, 2001; Gartlehner et al., 2011; Vaswani et al., 2003).”
BackgroundPierre Olié, J., & Kasper, S. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007766 · Cited by 256
“Agomelatine offered severely depressed patients similar advantages as seen in the ITT population ; an important finding, given that these patients are difficult to treat and frequently fail to recover or suffer recurrent episodes of depression because of inadequate symptom relief with some treatments, including SSRIs…”
BackgroundInfluentialHieronymus, F., Emilsson, J. F., Nilsson, S., & Eriksson, E. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.53 · Cited by 201
“27 than in the present study may at least partly be explained by SSRIs causing disturbed sleep as a side effect, 31 while tricyclic antidepressants exert a non-speci fi c sedative effect by antagonizing histaminergic H1 receptors.”
The Small Molecule Harmine Is an Antidiabetic Cell-Type-Specific Regulator of PPARγ Expression
Waki, H., Park, K. W., Mitro, N., Pei, L., Damoiseaux, R., Wilpitz, D. C., Reue, K., Saez, E., & Tontonoz, P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.010 · Cited by 202
Zuranolone for the Treatment of Postpartum Depression
Deligiannidis, K. M., Meltzer-Brody, S., Maximos, B., Peeper, E. Q., Freeman, M., Lasser, R., Bullock, A., Kotecha, M., Li, S., Forrestal, F., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220785 · Cited by 192
Zou, L., Yeung, A., Li, C., Wei, G.-X., Chen, K. W., Kinser, P. A., Chan, J. S. M., & Ren, Z. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080195 · Cited by 188
“headache, dizziness, and increased blood pressure) [8].”
Cerniauskas, I., Winterer, J., de Jong, J. W., Lukacsovich, D., Yang, H., Khan, F., Peck, J. R., Obayashi, S. K., Lilascharoen, V., Lim, B. K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.005 · Cited by 187
“Moreover, treatment with antidepressants has numerous side effects, such as fatigue, sleep disturbances, weight and appetite, and sexual dysfunction (Fergusson, 2001).”
To Approach or Avoid: An Introductory Overview of the Study of Anxiety Using Rodent Assays
La-Vu, M., Tobias, B. C., Schuette, P. J., & Adhikari, A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00145 · Cited by 182
“Side effects of SSRIs can include loss of appetite, lowered sex drive, and insomnia (Ferguson, 2001).”
BackgroundHausenblas, H. A., Saha, D., Dubyak, P. J., & Anton, S. D. (2013) · Journal of Integrative Medicine · doi:10.3736/jintegrmed2013056 · Cited by 176
Mechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Psychedelics and Other Psychoplastogens for Treating Mental Illness.
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M., & Olson, D. E. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.727117 · Cited by 166
Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S. A., & Mohajeri, S. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.035 · Cited by 165
Zhu, R., Fang, Y., Li, H., Liu, Y., Wei, J., Zhang, S., Wang, L., Fan, R., Wang, L., Li, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158137 · Cited by 166
Should antidepressants be used for major depressive disorder?
Jakobsen, J. C., Gluud, C., & Kirsch, I. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111238 · Cited by 162
“49 Moreover, because the evidence base consists of short-term trials, it is likely that the current estimates of adverse effects of antidepressants are underestimated.”
InfluentialPatki, G., Li, L., Allam, F., Solanki, N., Dao, A. T., Alkadhi, K., & Salim, S. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.03.016 · Cited by 152
“Although SSRIs are recommended to treat PTSD associated depression and anxiety, they cause adverse side effects such as sexual dysfunction, weight gain and sleep disturbances [54].”
BackgroundWei, C.-L., Wang, S., Yen, J.-T., Cheng, Y.-F., Liao, C.-L., Hsu, C.-C., Wu, C.-C., & Tsai, Y.-C. (2019) · Brain Research · doi:10.1016/j.brainres.2019.01.025 · Cited by 150
“Despite SSRIs having better overall safety and tolerability than older antidepressants, troublesome adverse effects such as sexual dysfunction, weight gain, and sleep disturbance might arise in long-term SSRI therapy (Ferguson, 2001).”
Is increased antidepressant exposure a contributory factor to the obesity pandemic?
Lee, S. H., Paz-Filho, G., Mastronardi, C., Licinio, J., & Wong, M.-L. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.25 · Cited by 139
Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms
Moore, A. C., Beidler, J., & Hong, M. Y. (2018) · Molecules · doi:10.3390/molecules23092197 · Cited by 151
“For many, the side effects of antidepressants are deleterious [8].”
BackgroundA treatment algorithm for neuropathic pain
Namaka, M., Gramlich, C., Ruhlen, D., Melanson, M., Sutton, I., & Major, J. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90171-3 · Cited by 156
Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret, C., Isaac, M., & Briley, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093582 · Cited by 135
“On the contrary, sertraline tends to reduce nocturnal wakening (Ferguson, 2001).”
BackgroundInfluentialBrust, R. D., Corcoran, A. E., Richerson, G. B., Nattie, E., & Dymecki, S. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.027 · Cited by 131
Pathological Laughing and Crying: Epidemiology, Pathophysiology and Treatment
Wortzel, H. S., Oster, T. J., Anderson, C. A., & Arciniegas, D. B. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00001 · Cited by 136
Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components
Morlion, B. J. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.534446 · Cited by 136
Fiest, K. M., Hitchon, C. A., Bernstein, C. N., Peschken, C. A., Walker, J. R., Graff, L. A., Zarychanski, R., Abou-Setta, A., Patten, S. B., Sareen, J., et al. (2017) · JCR: Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000489 · Cited by 123
Massoudi, B., Holvast, F., Bockting, C. L. H., Burger, H., & Blanker, M. H. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.050 · Cited by 101
Hudson, J. I., Wohlreich, M. M., Kajdasz, D. K., Mallinckrodt, C. H., Watkin, J. G., & Martynov, O. V. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.696 · Cited by 115
“However, longer-term therapy has been associated with treatment-emergent sexual dysfunction and weight gain, which may adversely affect patient compliance (Ferguson, 2001).”
Ghajar, A., Neishabouri, S., Velayati, N., Jahangard, L., Matinnia, N., Haghighi, M., Ghaleiha, A., Afarideh, M., Salimi, S., Meysamie, A., et al. (2017) · Pharmacopsychiatry · doi:10.1055/s-0042-116159 · Cited by 110
“Dur - ing SSRI therapy, the most troubling adverse effects are sexual dys - function, gastrointestinal disturbances, weight gain, anxiety, agitation, and sleep disturbances [18–20].”
Zirak, N., Shafiee, M., Soltani, G., Mirzaei, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27781 · Cited by 131
“Moreover, SSRIs are associated with a number of adverse health outcomes, including gastrointestinal effects, sleep disturbances, sexual dysfunction, weight gain and/or weight loss, hypomania, the syndrome of inappropriate antidiuretic hormone secretion, and movement disorders (Ferguson, 2001).”
BackgroundTreatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention
Hamner, M. B., Robert, S., & Frueh, B. C. (2004) · CNS Spectrums · doi:10.1017/s1092852900022380 · Cited by 109
Oral health impacts of medications used to treat mental illness
Cockburn, N., Pradhan, A., Taing, M., Kisely, S. R., & Ford, P. J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.037 · Cited by 137
Mika, J., Żychowska, M., Makuch, W., Rojewska, E., & Przewłocka, B. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71522-6 · Cited by 110
“In some cases, a low dose of a cyclic antidepressant may be added to another antidepressant, such as an selective serotonin reuptake inhibitor (SSRI), to increase the antidepressant effect [13].”
BackgroundAntidépresseurs et tolérance : déterminants et prise en charge des principaux effets indésirables
David, D. J., & Gourion, D. (2016) · L'Encéphale · doi:10.1016/j.encep.2016.05.006 · Cited by 105
Tolerability and safety of fluvoxamine and other antidepressants
Westenberg, H. G. M., & Sandner, C. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2006.00865.x · Cited by 103
Serotonin receptor 4 in the hippocampus modulates mood and anxiety
Karayol, R., Medrihan, L., Warner‐Schmidt, J. L., Fait, B. W., Rao, M. N., Hölzner, E., Greengard, P., Heintz, N., & Schmidt, E. F. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00994-y · Cited by 121
Keefe, J. R., Mao, J. J., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.10.013 · Cited by 102
“However, the commonly used selective serotonin reuptake inhibitors are often associated with weight gain, insomnia, daytime somnolence, jitteriness, agitation, and sexual side effects (Ferguson, 2001; Goethe et al., 2007).”
BackgroundAntidepressants for Preventive Treatment of Migraine
Burch, R. C. (2019) · Current Treatment Options in Neurology · doi:10.1007/s11940-019-0557-2 · Cited by 121
Maund, E., Dewar-Haggart, R., Williams, S., Bowers, H., Geraghty, A. W. A., Leydon, G., May, C., Dawson, S., & Kendrick, T. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.107 · Cited by 90
The effect of listening to holy quran recitation on anxiety: A systematic review
Ghiasi, A., & Keramat, A. (2018) · Iranian Journal of Nursing and Midwifery Research · doi:10.4103/ijnmr.ijnmr_173_17 · Cited by 100
“com interventions such as selective serotonin reuptake inhibitors (SSRIs) have been traditionally used in the treatment of anxiety, some cannot use these drugs because of side‐effects or interactions and others prefer not to use any medications.[3,6] Recently, a range of non‐pharmacological methods, such as aromathera…”
BackgroundSartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B., Brand, U., Fleischhacker, W., Goodwin, G., Grunze, H., Knapp, M., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98
Strategies to reduce use of antidepressants
Kendrick, T. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14475 · Cited by 96
“The SSRIs frequently cause significant weight change, sleep disturbance and sexual dysfunction.(15) Anti-”
BackgroundSexual dysfunction in Parkinson's disease
Meco, G., Rubino, A., Caravona, N., & Valente, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.10.008 · Cited by 102
Khan, A., Bose, A., Alexopoulos, G. S., Gommoll, C., Li, D., & Gandhi, C. C. (2007) · Clinical Drug Investigation · doi:10.2165/00044011-200727070-00005 · Cited by 97
Mariani, N., Cattane, N., Pariante, C. M., & Cattaneo, A. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01469-6 · Cited by 111
Rajpurkar, P., Yang, J., Dass, N., Vale, V., Keller, A. S., Irvin, J., Taylor, Z., Basu, S., Ng, A., & Williams, L. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.6653 · Cited by 88
Clayton, A. H., Lasser, R., Parikh, S. V., Iosifescu, D. V., Jung, J., Kotecha, M., Forrestal, F., Jonas, J., Kanes, S. J., & Doherty, J. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220459 · Cited by 87
Managing antidepressant discontinuation: a systematic review
Maund, E., Stuart, B., Moore, M., Dowrick, C., Geraghty, A. W. A., Dawson, S., & Kendrick, T. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2336 · Cited by 82
Premature ejaculation: old story, new insights
Jannini, E. A., Ciocca, G., Limoncin, E., Mollaioli, D., Sante, S. D., Gianfrilli, D., Lombardo, F. P., & Lenzi, A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.08.035 · Cited by 89
“In chronic SSRI therapy, the most troubling adverse effects are sexual dysfunction (hypoactive sexual desire disorder, erectile dysfunction, anorgasmia, anejaculation), weight gain, and sleep disturbance (135).”
BackgroundSerotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis
Li, B., Elsten-Brown, J., Li, M., Zhu, E., Li, Z., Chen, Y., Kang, E., Ma, F., Chiang, J., Li, Y.-R., et al. (2025) · Cell · doi:10.1016/j.cell.2025.04.032 · Cited by 103
“35, 36,39 The molecular machinery of the serotonergic system has long been known to exist in various immune cells, yet the precise role of serotonin in immunoregulation remains underexplored.”
Tan, A., Costi, S., Morris, L. S., Van Dam, N. T., Kautz, M., Whitton, A. E., Friedman, A. K., Collins, K. A., Ahle, G., Chadha, N., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0283-2 · Cited by 80
Overuse of Antidepressant Drugs for the Treatment of Depression
Jureidini, J. N., & Tonkin, A. (2006) · CNS Drugs · doi:10.2165/00023210-200620080-00002 · Cited by 89
Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials
Liu, B., He, Y., Wang, M., Liu, J., Ju, Y., Zhang, Y., Liu, T., Li, L., & Li, Q. (2018) · Depression and Anxiety · doi:10.1002/da.22811 · Cited by 81
“…of current drugs for anxiety disorders are common and often frustrating; these effects include GI reactions and sexual dysfunction due to selective serotonin reuptake inhibitors (Ferguson, 2001; Kennedy & Rizvi, 2009), aswell as potential addiction to benzodiazepines (Ashton, 1997), among others.”
BackgroundMatheson, B. E., & Douglas, J. M. (2017) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-017-0103-7 · Cited by 81
Robinson, D. S., Kajdasz, D. K., Gallipoli, S., Whalen, H., Wamil, A., & Reed, C. R. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c6741 · Cited by 81
“8 kg reported during long-term SSRI therapy.(14) In this study, weight gain over 52 weeks of vilazodone treatment was small (1.”
BackgroundLi, Y., Peng, Y., Ma, P., Yang, H., Xiong, H., Wang, M., Peng, C., Tu, P., & Li, X. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00967 · Cited by 88
“However, these antidepressants have been shown to possess severe side effects including cardiac toxicity, blood pressure, sexual dysfunction, and sleep disorders (Ferguson, 2001; Jin et al., 2015).”
BackgroundLim, J., Bang, Y., & Choi, H. J. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1063-x · Cited by 84
Efficacy of Silexan in mixed anxiety–depression – A randomized, placebo-controlled trial
Kasper, S. F., Volz, H., Dienel, A., & Schläfke, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.002 · Cited by 82
“, 2013), have a more favourable safety profile than older drugs but are still associated with bothersome and partly disabling side effects such as anticholinergic reactions, headache, sedation, gastrointestinal complaints, somnolence, weight gain or sexual dysfunction (Ferguson, 2001).”
BackgroundTabeshpour, J., Sobhani, F., Sadjadi, S. A., Hosseinzadeh, H., Mohajeri, S. A., Rajabi, O., Taherzadeh, Z., & Eslami, S. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.10.005 · Cited by 90
Choi, Y. D., Park, C. W., Jang, J., Kim, S. H., Jeon, H. Y., Kim, W. G., Lee, S. J., & Chung, W. S. (2012) · International Journal of Impotence Research · doi:10.1038/ijir.2012.45 · Cited by 84
Anxiety: An ignored aspect of Parkinson’s disease lacking attention
Khatri, D. K., Choudhary, M., Sood, A., & Singh, S. B. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110776 · Cited by 94
Takahashi, M., Tabu, H., Ozaki, A., Hamano, T., Takeshima, T., & for the REBORN study group (2018) · Internal Medicine · doi:10.2169/internalmedicine.1359-18 · Cited by 86
“Gastrointestinal AEs, which are associated with SSRI treatment (29), were among the most”
BackgroundAmerican psychiatry in the new millennium: a critical appraisal
Scull, A. T. (2021) · Psychological Medicine · doi:10.1017/s0033291721001975 · Cited by 100
“Ferguson, J. (2001). SSRI antidepressant medications: Adverse effects and tolerability.”
BackgroundMandal, P. K., Gaur, S., Roy, R. G., Samkaria, A., Ingole, R., & Goel, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00420 · Cited by 88
Cooper, J. A., Tucker, V. L., & Papakostas, G. I. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113514878 · Cited by 76
“, 2005) such as myalgia, asthenia and headache, which are also common side effects of SSRIs (Ferguson, 2001).”
BackgroundA Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders
Thapliyal, S., Singh, T., Handu, S. S., Bisht, M., Kumari, P., Arya, P., Srivastava, P., & Ravi, G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03257-6 · Cited by 87
Cicali, E. J., Weitzel, K. W., Elsey, A. R., Orlando, F. A., Vinson, M., Mosley, S. A., Smith, D. M., Davis, R., Drum, L., Estores, D. S., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0500-7 · Cited by 79
Treating depression With Tai Chi: state of the art and future perspectives
Kong, J., Wilson, G., Park, J., Pereira, K., Walpole, C., & Yeung, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00237 · Cited by 75
The effect of antidepressants and antipsychotics on weight gain in children and adolescents
Reekie, J., Hosking, S. P. M., Prakash, C., Kao, K. ‐., Juonala, M., & Sabin, M. A. (2015) · Obesity Reviews · doi:10.1111/obr.12284 · Cited by 72
“This is similar to findings from adult studies of SSRIs, which demonstrate an initial weight loss effect in shortterm trials that later develops into a gain in weight over the longer term (41).”
ResultThe LIFE Model: A Meta-Theoretical Conceptual Map for Applied Positive Psychology
Lomas, T., Hefferon, K., & Ivtzan, I. (2015) · Journal of Happiness Studies · doi:10.1007/s10902-014-9563-y · Cited by 71
“biochemical ‘imbalances,’ as with selective serotonin reuptake inhibitor (SSRI) treatments (Ferguson 2001).”
BackgroundCrawford, A. A., Lewis, S., Nutt, D., Peters, T. J., Cowen, P., O’Donovan, M. C., Wiles, N., & Lewis, G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3467-8 · Cited by 69
“The GENPOD study has allowed a detailed comparison between two pharmacologically different antidepressants, citalopram and reboxetine.”
InfluentialPrevalence and Predictors of Poor Sleep Quality in Mild Cognitive Impairment
McKinnon, A. C., Terpening, Z., Hickie, I. B., Batchelor, J., Grunstein, R. R., Lewis, S. J. G., & Naismith, S. L. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714527516 · Cited by 79
“In samples with depression, the use of antidepressants may alter sleep architecture, increasing latency to rapid eye movement (REM) sleep and decreasing the amount of time spent in slow wave sleep.(23,24) These interrelationships have not yet been examined in patients with MCI.”
BackgroundGanci, M., Suleyman, E., Butt, H., & Ball, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1408 · Cited by 83
“…ben‐ eficial, such treatments may induce undesirable side effects includ‐ ing, but not limited to, nausea, sleep disturbance, weight gain, and sexual dysfunction (Ferguson, 2001) all of which may themselves be a result of microbe‐mediated drug metabolism (Enright, Joyce, Gahan, & Griffin, 2017).”
BackgroundHacke, A. C. M., Miyoshi, E., Marques, J. A., & Pereira, R. P. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113036 · Cited by 82
Breedvelt, J. J. F., Warren, F. C., Segal, Z., Kuyken, W., & Bockting, C. L. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0823 · Cited by 68
Fast-Scan Cyclic Voltammetry Analysis of Dynamic Serotonin Reponses to Acute Escitalopram
Wood, K. M., & Hashemi, P. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4000378 · Cited by 68
Modulating Oxidative Stress Relieves Stress-Induced Behavioral and Cognitive Impairments in Rats
Solanki, N., Salvi, A., Patki, G., & Salim, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx017 · Cited by 72
“…are regarded as the “gold standard” of treatment, these are associated with severe side effects including, but not limited to, tolerance, withdrawal effects, memory dysfunction, and significant weight gain (Gudex, 1991; Ashton, 1994; Trindade et al., 1998; Ferguson, 2001; Barker et al., 2004).”
BackgroundUse of Antidepressants among Patients Diagnosed with Depression: A Scoping Review
Marasine, N. R., Sankhi, S., Lamichhane, R., Marasini, N. R., & Dangi, N. B. (2021) · BioMed Research International · doi:10.1155/2021/6699028 · Cited by 84
“Antidepressants other than SSRIs nonselectively inhibit the reuptake of norepinephrine, dopamine, and serotonin into presynaptic vesicles and affect adrenergic, cholinergic, postsynaptic serotonin, and histaminic receptors in the brain, which are unrelated to depression, leading to intolerable adverse effects [47].”
BackgroundHett, D., Rogers, J. C., Humpston, C. S., & Marwaha, S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.058 · Cited by 72
Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review
Romanescu, M., Buda, V. O., Lombrea, A., Andor, M., Ledeţi, I., Suciu, M., Danciu, C., Dehelean, C. A., & Dehelean, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060907 · Cited by 74
Kongpakwattana, K., Sawangjit, R., Tawankanjanachot, I., Bell, J. S., Hilmer, S. N., & Chaiyakunapruk, N. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13604 · Cited by 69
Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression
Ko, Y., Kim, S., Lee, S., & Jang, C. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01292-5 · Cited by 72
“However, medication, such as antidepressants, has low efficacy in association with the treatment of mental disorders, and results in several side effects, including nausea, insomnia, dry mouth, fatigue, as well as sexual problems (Ferguson 2001; Xu et al.”
BackgroundDiscontinuing Psychiatric Medications: A Survey of Long-Term Users
Ostrow, L., Jessell, L., Hurd, M., Darrow, S. M., & Cohen, D. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700070 · Cited by 62
Croft, H. A., Pomara, N., Gommoll, C., Chen, D., Nunez, R., & Mathews, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m08992 · Cited by 61
Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling
Scriven, M., Dinan, T. G., Cryan, J. F., & Wall, M. (2018) · Diseases · doi:10.3390/diseases6030078 · Cited by 63
“Additionally, some of the side-effects produced by psychotropic medication impact negatively on patient’s functioning, examples include weight gain and sexual dysfunction [2].”
BackgroundSmits, K., Smits, L., Peeters, F., Schouten, J., Janssen, R., Smeets, H., Os, J. V., & Prins, M. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328014822a · Cited by 62
“This division is identical to a previous study on SSRI-induced adverse events (Ferguson, 2001).”
BackgroundResultInfluentialWhole-genome association analysis of treatment response in obsessive-compulsive disorder
Qin, H., Samuels, J. F., Wang, Y., Zhu, Y., Grados, M. A., Riddle, M. A., Greenberg, B. D., Knowles, J. A., Fyer, A. J., McCracken, J. T., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.32 · Cited by 61
Khazaie, H., Rezaie, L., Payam, N. R., & Najafi, F. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.10.010 · Cited by 82
“SSRI-induced sexual dysfunction has been reported in previous studies [6–11].”
A practical guide to secondary pharmacology in drug discovery
Jenkinson, S. G., Schmidt, F., Ribeiro, L. R., Delaunois, A. G., & Valentin, J. (2020) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2020.106869 · Cited by 67
Metadata
- Authors
- Ferguson, J. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Ferguson, James M.
- ORCID
- Ferguson, James M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-01
- Volume
- 3
- Issue
- 1
- Pages
- 22-27
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- PMC
- PMC181155
- OpenAlex
- W2024985387
- Cited by
- 669
- References
- 23
- Citations by year
- 2026: 26 · 2025: 35 · 2024: 33 · 2023: 46 · 2022: 63 · 2021: 69 · 2020: 56 · 2019: 64 · 2018: 45 · 2017: 47 · 2016: 36 · 2015: 28 · 2014: 27 · 2013: 24 · 2012: 11
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Primary Care Companion For CNS Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, antidepressant side effects, sexual dysfunction, weight gain, sleep disorders, depression treatment, primary care management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.